Delivery Order SPE2DB22D1017-SPE2DB25FF9AD
Award Date
4/1/25
Potential Completion Date
4/2/25
Potential Value
$1.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $1,352.64 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of BUDESONIDE-FORMOTEROL 160-4.5 10.2GM, a pharmaceutical product, with a completion date of February 7, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical for providing a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,793.42 firm fixed-price contract is for the supply of BUDESONIDE-FORMOTEROL 160-4.5 10.2GM, a medical product, with a period of performance through December 16, 2024. The award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,114.39 firm fixed-price contract is for the supply of BUDESONIDE-FORMOTEROL 160-4.5 10.2GM, a medical product. The contract has an ultimate completion date of March 12, 2025 and was awarded on March 11, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BUDESONIDE-FORMOTEROL 160-4.5 10.2GM, a medical product, with a ceiling value of $8,568.40 and a period of performance through March 13, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $3,478.12, is for the delivery of BUDESONIDE-FORMOTEROL 160-4.5 10.2GM, a pharmaceutical product. This is a firm fixed-price delivery order contract with an ultimate completion date of April 4, 2025. The contract was awarded on April 3, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,863.85, is for the supply of BUDESONIDE-FORMOTEROL 160-4.5 10.2GM, a medical product. The contract has an ultimate completion date of December 12, 2023 and is a Firm Fixed Price contract type. This award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of BUDESONIDE-FORMOTEROL 80-4.5 10.2GM, a pharmaceutical product, with a ceiling value of $1,671.50 and a period of performance through April 2, 2025. The contract is a Delivery Order and is priced on a Firm Fixed Price basis. It is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a significant...
This federal contract award, valued at $1,143.12, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of BUDESONIDE-FORMOTEROL 80-4.5 10.2GM, a medical product, with a completion date of January 16, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type, and is not designated as a Set-Aside. Amerisourcebergen Drug Corp holds a significant...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,364.22 firm fixed-price contract is for the supply of BUDESONIDE-FORMOTEROL 160-4.5 10.2GM, a pharmaceutical product, with a performance period through November 15, 2024. This award is associated with Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,341.39, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. The IDC, worth $999,999,999, provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific Delivery...